Latest period
$348.00M
YoY change
+32.0%
5Y CAGR
+24.6%
Peak year (2025)
$4.53B
Latest annual
$4.53B
Operating Cash Flow history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: $4.53B
Operating Cash Flow growth chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +32.0%
Operating Cash Flow history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | $4.53B | +32.0% | +$1.10B | ||
| 2024 | $3.44B | +37.2% | +$932.00M | ||
| 2023 | $2.50B | +64.0% | +$977.00M | ||
| 2022 | $1.53B | -18.4% | −$344.00M | ||
| 2021 | $1.87B | +24.0% | +$362.00M | ||
| 2020 | $1.51B | -17.9% | −$328.00M | ||
| 2019 | $1.84B | +492.3% | +$1.53B | ||
| 2018 | $310.00M | -78.3% | −$1.12B | ||
| 2017 | $1.43B | +46.7% | +$454.00M | ||
| 2016 | $972.00M | +62.0% | +$372.00M | ||
| 2015 | $600.00M | -52.7% | −$669.00M | ||
| 2014 | $1.27B | +17.3% | +$187.00M | ||
| 2013 | $1.08B | -14.1% | −$178.00M | ||
| 2012 | $1.26B | +25.0% | +$252.00M | ||
| 2011 | $1.01B | +210.2% | +$683.00M | ||
| 2010 | $325.00M | -61.1% | −$510.00M | ||
| 2009 | $835.00M | -31.3% | −$381.00M | ||
| 2008 | $1.22B | +30.2% | +$282.00M | ||
| 2007 | $934.00M | -49.4% | −$911.00M | ||
| 2006 | $1.84B | +104.3% | +$942.00M | ||
| 2005 | $903.00M | -49.9% | −$901.00M | ||
| 2004 | $1.80B | +129.2% | +$1.02B | ||
| 2003 | $787.00M | +6.9% | +$51.00M | ||
| 2002 | $736.00M | +50.2% | +$246.00M | ||
| 2001 | $490.00M | -33.7% | −$249.00M | ||
| 2000 | $739.00M | +1.7% | +$12.00M | ||
| 1999 | $727.00M | +181.2% | +$468.50M | ||
| 1998 | $258.50M | +221.1% | +$178.00M | ||
| 1997 | $80.50M | -40.1% | −$53.80M | ||
| 1996 | $134.30M | +437.2% | +$109.30M | ||
| 1995 | $25.00M | -63.1% | −$42.80M | ||
| 1994 | $67.80M | +3.0% | +$2.00M | ||
| 1993 | $65.80M | +54.8% | +$23.30M | ||
| 1992 | $42.50M | +43.6% | +$12.90M | ||
| 1991 | $29.60M | — | — |
- 2025$4.53B+32.0%
- 2024$3.44B+37.2%
- 2023$2.50B+64.0%
- 2022$1.53B-18.4%
- 2021$1.87B+24.0%
- 2020$1.51B-17.9%
- 2019$1.84B+492.3%
- 2018$310.00M-78.3%
- 2017$1.43B+46.7%
- 2016$972.00M+62.0%
- 2015$600.00M-52.7%
- 2014$1.27B+17.3%
- 2013$1.08B-14.1%
- 2012$1.26B+25.0%
- 2011$1.01B+210.2%
- 2010$325.00M-61.1%
- 2009$835.00M-31.3%
- 2008$1.22B+30.2%
- 2007$934.00M-49.4%
- 2006$1.84B+104.3%
- 2005$903.00M-49.9%
- 2004$1.80B+129.2%
- 2003$787.00M+6.9%
- 2002$736.00M+50.2%
- 2001$490.00M-33.7%
- 2000$739.00M+1.7%
- 1999$727.00M+181.2%
- 1998$258.50M+221.1%
- 1997$80.50M-40.1%
- 1996$134.30M+437.2%
- 1995$25.00M-63.1%
- 1994$67.80M+3.0%
- 1993$65.80M+54.8%
- 1992$42.50M+43.6%
- 1991$29.60M—
Operating Cash Flow values are taken from Boston Scientific's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Boston Scientific (BSX)
Operating Cash Flow for Boston Scientific (BSX): headline value $348.00M · YoY +32.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Boston Scientific (BSX) most recent annual operating cash flow stands at $4.53B (2025) – surged 32.0% year-over-year.
Boston Scientific operating cash flow compound annual growth for the 2020–2025 (5 years) window is +24.6%, sustaining 3 straight years of year-over-year growth.
Across the available history, operating cash flow reached its high of $4.53B in 2025 and its low of $25.00M in 1995.
Boston Scientific Operating Cash Flow by Year
Boston Scientific Operating Cash Flow 2025: $4.53B
In 2025, Boston Scientific reported operating cash flow of $4.53B, surged 32.0% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Operating Cash Flow 2024: $3.44B
Boston Scientific operating cash flow in 2024 was $3.44B, surged 37.2% from 2023.
Boston Scientific Operating Cash Flow 2023: $2.50B
2023's operating cash flow for Boston Scientific came in at $2.50B, surged 64.0% from 2022.
Boston Scientific Operating Cash Flow 2022: $1.53B
Boston Scientific posted operating cash flow of $1.53B in 2022, declined 18.4% below 2021.
Boston Scientific Operating Cash Flow 2021: $1.87B
Boston Scientific operating cash flow in 2021 was $1.87B.
See more financial history for Boston Scientific (BSX).
Sector peers by Operating Cash Flow
Healthcare peers of Boston Scientific (BSX), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation